This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): 3 mg drospirenone and 30 mcg ethinyl estradiol
Description: Yasmin is a low-dose, monophasic oral contraceptive that combines 3 mg drospirenone and 30 microg ethinyl estradiol and supresses gonadotropins.
Pink Sheet Low-Dose Yasmin Review Slows
Pink Sheet Yasmin Paragraph IV filing
Pink Sheet Bayer Puts Marketing Muscle Behind Yaz
Additional information available to subscribers only: